{"id":"ultra-fluid-lipiodol","safety":{"commonSideEffects":[{"rate":null,"effect":"Iodine hypersensitivity reaction"},{"rate":null,"effect":"Hepatic toxicity"},{"rate":null,"effect":"Vascular occlusion complications"},{"rate":null,"effect":"Postembolization syndrome"}]},"_chembl":{"chemblId":"CHEMBL1200559","moleculeType":"Small molecule","molecularWeight":"90.08"},"_fixedAt":"2026-03-30T17:14:31.389472","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lipiodol is an ethiodized oil that contains iodine, providing radiopacity for visualization under fluoroscopy and X-ray imaging. The ultra-fluid formulation allows for improved flow characteristics and penetration into target vessels, making it suitable for both diagnostic angiography and therapeutic embolization procedures. It is commonly used in hepatocellular carcinoma treatment via transarterial chemoembolization (TACE) and other vascular interventions.","oneSentence":"Ultra-fluid lipiodol is a radiopaque iodized oil suspension used as a contrast agent and embolic material for diagnostic imaging and interventional procedures.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:51:46.590Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diagnostic imaging in angiography and vascular procedures"},{"name":"Transarterial chemoembolization (TACE) for hepatocellular carcinoma"},{"name":"Therapeutic embolization of vascular lesions"}]},"_fixedFields":["pubmed(26)"],"trialDetails":[{"nctId":"NCT02625389","phase":"PHASE4","title":"A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures","status":"COMPLETED","sponsor":"Guerbet","startDate":"2017-11-29","conditions":"Congenital Hemangioma, Hemangioendothelioma, Angiosarcoma","enrollment":132},{"nctId":"NCT05882188","phase":"NA","title":"The Cost-effectiveness of Hysterosalpingography Versus Hysterosalpingo-foam Sonography During Fertility Work-up","status":"RECRUITING","sponsor":"Amsterdam UMC, location VUmc","startDate":"2023-09-22","conditions":"Infertility","enrollment":1102},{"nctId":"NCT04178642","phase":"PHASE2","title":"The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-Lipiodol","status":"WITHDRAWN","sponsor":"University Hospital, Montpellier","startDate":"2020-09-22","conditions":"Hepatocellular Carcinoma","enrollment":""},{"nctId":"NCT03604549","phase":"PHASE4","title":"Sonographic Hysterosalpingography: Oil vs Water Based Media (SHOW Trial)","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2019-01-11","conditions":"Infertility","enrollment":58},{"nctId":"NCT03649113","phase":"PHASE1","title":"Percutaneous Sclerotherapy of Symptomatic Liver Hemangioma With Bleomycin","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2018-09-01","conditions":"Hemangioma Liver","enrollment":25},{"nctId":"NCT02971345","phase":"PHASE3","title":"Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2017-01","conditions":"Hepatocellular Carcinoma, Portal Vein Tumor Thrombus","enrollment":253},{"nctId":"NCT03116984","phase":"PHASE3","title":"A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2017-01-01","conditions":"Hepatocellular Carcinoma","enrollment":300},{"nctId":"NCT03510416","phase":"PHASE2","title":"Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2018-05-01","conditions":"Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization","enrollment":22},{"nctId":"NCT02956772","phase":"PHASE2","title":"Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients","status":"UNKNOWN","sponsor":"Hunan Provincial People's Hospital","startDate":"2016-11","conditions":"Primary Hepatocellular Carcinoma","enrollment":190},{"nctId":"NCT02630108","phase":"PHASE3","title":"TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2015-12","conditions":"Carcinoma, Hepatocellular","enrollment":280},{"nctId":"NCT02631499","phase":"PHASE4","title":"Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2015-12","conditions":"Carcinoma, Hepatocellular, Neoplastic Cells, Circulating","enrollment":256},{"nctId":"NCT00609843","phase":"NA","title":"Pilot Studie of Lipiodol Demarcation of the Tumour in Bladder Cancer","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2008-02","conditions":"Bladder Cancer","enrollment":5},{"nctId":"NCT02018757","phase":"PHASE2","title":"Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC","status":"UNKNOWN","sponsor":"First Hospital of China Medical University","startDate":"2014-01","conditions":"Carcinoma, Hepatocellular","enrollment":250}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":26,"recentPublications":[{"date":"2025 Sep 18","pmid":"40976892","title":"Comparison of the Diagnostic Consistency between Delayed Radiographs taken Two Hours and Twenty-four Hours Post Hysterosalpingography using Ultra-Fluid Lipiodol-based Contrast Medium.","journal":"Current medical imaging"},{"date":"2023 Dec","pmid":"37038342","title":"Efficacy of transcatheter arterial chemoembolization combined with sirolimus for treating Kasabach-Merritt phenomenon in infants, a retrospective study.","journal":"Annals of medicine"},{"date":"2013 Feb","pmid":"23444241","title":"Arsenic trioxide treatment of rabbit liver VX-2 carcinoma via hepatic arterial cannulation-induced apoptosis and decreased levels of survivin in the tumor tissue.","journal":"Croatian medical journal"},{"date":"2013 Aug","pmid":"22092375","title":"The effect of surrounding conditions on pixel value of cone beam computed tomography.","journal":"Clinical oral implants research"},{"date":"2010 Jan","pmid":"19495755","title":"Phase I/II study of the lipiodolization using DDP-H (CDDP powder; IA-call(®)) in patients with unresectable hepatocellular carcinoma.","journal":"Cancer chemotherapy and pharmacology"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["lipiodol"],"phase":"phase_3","status":"active","brandName":"Ultra-fluid lipiodol","genericName":"Ultra-fluid lipiodol","companyName":"Shanghai Zhongshan Hospital","companyId":"shanghai-zhongshan-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ultra-fluid lipiodol is a radiopaque iodized oil suspension used as a contrast agent and embolic material for diagnostic imaging and interventional procedures. Used for Diagnostic imaging in angiography and vascular procedures, Transarterial chemoembolization (TACE) for hepatocellular carcinoma, Therapeutic embolization of vascular lesions.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}